CAMBRIDGE, MA—Medical conditions ranging from breast cancer to post traumatic stress disorder could be diagnosed much more quickly by using magnetic resonance spectroscopy (MRS)—a type of MRI that measures the chemical content of tissues and organs—according to researchers. Given the promising potential for MRS as a diagnostic technology, the medical community is eager to explore various applications. To support this effort, Draper recently hosted a meeting with Premier Annastacia Palaszczuk, of Queensland, Australia, and a team from Harvard University, the Innovation and Translation Centre at Brisbane’s Translational Research Institute (TRI), Siemens Healthineers and Queensland University of Technology to discuss MRS and artificial intelligence during a recent Australian trade mission to Draper’s offices in Cambridge.
Draper combines specific domain expertise and knowledge of how to apply the latest analytics techniques to extract meaningful information from raw data to better understand complex, dynamic processes. Our system design approach encompasses effective organization and processing of large data sets, automated analysis using algorithms and exploitation of results. To facilitate user interaction with these processed data sets, Draper applies advanced techniques to automate understanding and correlation of patterns in the data. Draper’s expertise encompasses machine learning (including deep learning), information fusion from diverse and heterogeneous data sources, optimized coupling of data acquisition and analysis and novel methods for analysis of imagery and video data.
Draper’s Biomedical Solutions capability centers on the application of microsystems, miniaturized electronics, computational modeling, algorithm development and image and data analytics applied to a range of challenges in healthcare and related fields. Draper fills that critical engineering niche that is required to take research or critical requirements and prototype or manufacture realizable solutions. Some specific examples are MEMS, microfluidics and nanostructuring applied to the development of wearable and implantable medical devices, organ-assist devices and drug-delivery systems. Novel neural interfaces for prosthetics and for treatment of neurological conditions are being realized through a combination of integrated miniaturized electronics and microfabrication technologies.